Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review

por Salloum, Naji C., Fava, Maurizio, Ball, Sophia, Papakostas, George I.
Publicado en Mol Psychiatry (2020)

Towards the clinical implementation of pharmacogenetics in bipolar disorder

por Salloum, Naji C, McCarthy, Michael J, Leckband, Susan G, Kelsoe, John R
Publicado 2014

A Reciprocal Effects Analysis of Cannabis Use and Perceptions of Risk

por Salloum, Naji C., Krauss, Melissa J., Agrawal, Arpana, Bierut, Laura J., Grucza, Richard A.
Publicado en Addiction (2018)

Time to Relapse after a Single Administration of Intravenous Ketamine Augmentation in Unipolar Treatment-Resistant Depression

por Salloum, Naji C., Fava, Maurizio, Hock, Rebecca S., Freeman, Marlene P., Flynn, Martina, Hoeppner, Bettina, Cusin, Cristina, Iosifescu, Dan V., Trivedi, Madhukar H., Sanacora, Gerard, Mathew, Sanjay J., Debattista, Charles, Ionescu, Dawn F., Papakostas, George I.
Publicado en J Affect Disord (2019)

From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation

por Salloum, Naji C, Buchalter, Erica LF, Chanani, Swati, Espejo, Gemma, Ismail, Mahjabeen S, Laine, Randy O, Nageeb, Maysaa, Srivastava, A Benjamin, Trapp, Nicholas, Trillo, Ludwig, Vance, Erica, Wenzinger, Michael, Hartz, Sarah M, David, Sean P, Chen, Li-Shiun
Publicado en Pharmacogenomics (2018)